TrialDiabetes, obesity & metabolism2019

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study.

Niina Matikainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.